2.07

1.90% -0.04

Vivos Therapeutics Inc (VVOS)

Overview News Price History Financials Discussions Forecast Stock Split

Vivos Therapeutics Inc stock is traded at $2.07, with a volume of 116.53K. It is down -1.90% in the last 24 hours and down -17.86% over the past month. Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Previous Close:

$2.11

Open:

$2.18

24h Volume:

116.53K

Relative Volume:

0.43

Market Cap:

$18.61M

Revenue:

$14.58M

Net Income/Loss:

$-12.57M

P/E Ratio:

-0.3644

EPS:

-5.68

Net Cash Flow:

$-13.07M

1W Performance:

+0.00%

1M Performance:

-17.86%

6M Performance:

-2.82%

1Y Performance:

-53.48%

1-Day Range:

$2.04

$2.1834

1-Week Range:

$2.04

$2.28

52-Week Range:

$1.98

$7.95

Vivos Therapeutics Inc Stock (VVOS) Company Profile

Name

Vivos Therapeutics Inc

Sector

Healthcare (1123)

Industry

Medical Devices (141)

Phone

(866)908-4867

Address

7921 SOUTHPARK PLAZA,, LITTLETON

Employee

109

Twitter

Next Earnings Date

2025-08-19

Latest SEC Filings

VVOS's Discussions on Twitter

Compare VVOS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VVOS Vivos Therapeutics Inc	2.07	18.96M	14.58M	-12.57M	-13.07M	-5.68
ABT Abbott Laboratories	125.46	214.37B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	92.58	136.01B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	354.09	134.98B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	99.87	127.88B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	83.08	48.88B	5.88B	1.34B	799.60M	2.3489

Vivos Therapeutics Inc Stock (VVOS) Latest News

Dec 12, 2025

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

Dec 12, 2025

Dec 11, 2025

Vivos Therapeutics Inc Stock Analysis and ForecastBull Market Opportunities & Use Our Sector Rotation Strategy for Gains - earlytimes.in

Dec 11, 2025

Dec 07, 2025

What analysts say about Vivos Therapeutics Inc stockPrice Momentum Alerts & What the Pros Are Saying About This Stock - earlytimes.in

Dec 07, 2025

Dec 06, 2025

Vivos Therapeutics secures $2M note with Avondale - MSN

Dec 06, 2025

Dec 05, 2025

Vivos Therapeutics Secures $2M Note with Avondale - TipRanks

Dec 05, 2025

Vivos Therapeutics, Inc. Enters into a Note Purchase Agreement with Avondale Capital, LLC - marketscreener.com

Dec 05, 2025

Can Vivos Therapeutics Inc. stock beat analyst upgradesJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - Newser

Dec 05, 2025

Is Vivos Therapeutics Inc. stock a buy for dividend growthEarnings Overview Summary & Low Drawdown Momentum Trade Ideas - Newser

Dec 05, 2025

Dec 04, 2025

Vivos Therapeutics, Inc. announced that it has received $2.09334 million in funding from Avondale Capital, LP - marketscreener.com

Dec 04, 2025

Vivos Therapeutics (NASDAQ:VVOS) Given New $5.50 Price Target at Ascendiant Capital Markets - Defense World

Dec 04, 2025

Is Vivos Therapeutics Inc. stock a smart buy before Fed meeting2025 Price Momentum & AI Enhanced Trading Alerts - Newser

Dec 04, 2025

Dec 03, 2025

VVOS: Ascendiant Capital Maintains Buy Rating, Lowers Price Targ - GuruFocus

Dec 03, 2025

Ascendiant Capital Maintains Vivos Therapeutics (VVOS) Buy Recommendation - Nasdaq

Dec 03, 2025

Vivos Therapeutics (VVOS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 03, 2025

Dec 01, 2025

Vivos Therapeutics Reports Strong Q3 Growth Amid Challenges - MSN

Dec 01, 2025

Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga

Dec 01, 2025

Nov 26, 2025